{"id":"W2083983329","doi":"10.1007/s10637-006-6406-7","title":"A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial","year":2006,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Mount Sinai Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Nausea; Vomiting; Sarcoma; Soft tissue sarcoma; Internal medicine; Adverse effect; Toxicity; Progressive disease; Surgery; Population; Dosing; Gastroenterology; Phases of clinical research; Chemotherapy; Soft tissue; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009308296,0.000241387,0.0006523748,0.00008873212,0.00006332294,0.000009794207,0.0002202557,0.00009022621,0.00005419854],"category_scores_gemma":[0.001251186,0.0001926487,0.00006662666,0.0003395317,0.0002188293,0.00002250311,0.00006035447,0.0001243306,2.521089e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001446168,"about_ca_system_score_gemma":0.006798187,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06350055,"about_ca_topic_score_gemma":0.2117997,"domain_scores_codex":[0.9967023,0.0003663695,0.001456775,0.0004468817,0.000799359,0.0002282885],"domain_scores_gemma":[0.9981269,0.0002018441,0.0008000607,0.0002081143,0.0005197089,0.0001433436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4543384,0.05399197,0.1114426,0.000615247,0.004243481,0.00007365194,0.001747801,0.1568194,0.09400805,0.00109191,0.04402081,0.07760663],"study_design_scores_gemma":[0.8401645,0.05579471,0.02359534,0.0008094588,0.0007371009,0.000007631925,0.0001942975,0.001183608,0.04330822,0.0009745695,0.03172424,0.001506345],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997057,0.0002678231,0.0003229751,0.0001411662,0.000303895,0.001619326,0.0002453723,0.000007101252,0.00003538691],"genre_scores_gemma":[0.9964613,0.000006290367,0.001814718,0.0001997065,0.0003171703,0.0001581668,0.0006234774,0.00002621893,0.0003929889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.385826,"threshold_uncertainty_score":0.9988323,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04329356748062302,"score_gpt":0.3666796670381587,"score_spread":0.3233860995575357,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}